
### [MONDO:0017970](http://purl.obolibrary.org/obo/MONDO_0017970)
**Label:** 46,XY disorder of sex development due to impaired androgen production

**Subclasses:** [MONDO:0009384](http://purl.obolibrary.org/obo/MONDO_0009384) (leydig cell hypoplasia, type 1), [MONDO:0020041](http://purl.obolibrary.org/obo/MONDO_0020041) (46,XY disorder of sex development due to a defect in testosterone metabolism by peripheral tissue), [MONDO:0017971](http://purl.obolibrary.org/obo/MONDO_0017971) (46,XY disorder of sex development due to a cholesterol synthesis defect), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0019155](http://purl.obolibrary.org/obo/MONDO_0019155) (leydig cell hypoplasia), [MONDO:0019595](http://purl.obolibrary.org/obo/MONDO_0019595) (46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0019596](http://purl.obolibrary.org/obo/MONDO_0019596) (46,XY disorder of sex development due to testicular steroidogenesis defect), [MONDO:0019594](http://purl.obolibrary.org/obo/MONDO_0019594) (46,XY disorder of sex development due to a testosterone synthesis defect), [MONDO:0018618](http://purl.obolibrary.org/obo/MONDO_0018618) (46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), 

**Corr. equiv. classes:** [OMIM:201710](http://purl.obolibrary.org/obo/OMIM_201710), [Orphanet:443090](http://www.orpha.net/ORDO/Orphanet_443090), [Orphanet:98086](http://www.orpha.net/ORDO/Orphanet_98086), [OMIM:202110](http://purl.obolibrary.org/obo/OMIM_202110), [Orphanet:325511](http://www.orpha.net/ORDO/Orphanet_325511), [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796), [Orphanet:90786](http://www.orpha.net/ORDO/Orphanet_90786), [Orphanet:90787](http://www.orpha.net/ORDO/Orphanet_90787), [Orphanet:90790](http://www.orpha.net/ORDO/Orphanet_90790), [Orphanet:90793](http://www.orpha.net/ORDO/Orphanet_90793), [Orphanet:755](http://www.orpha.net/ORDO/Orphanet_755), [OMIM:238320](http://purl.obolibrary.org/obo/OMIM_238320), [Orphanet:90783](http://www.orpha.net/ORDO/Orphanet_90783), 

**Class expressions from DL-Learner:**

- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0010936](http://purl.obolibrary.org/obo/HP_0010936) (Abnormality of the lower urinary tract) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000795](http://purl.obolibrary.org/obo/HP_0000795) (Abnormality of the urethra) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0010936](http://purl.obolibrary.org/obo/HP_0010936) (Abnormality of the lower urinary tract) and [HP:0030349](http://purl.obolibrary.org/obo/HP_0030349) (Decreased circulating androgen level) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0008187](http://purl.obolibrary.org/obo/HP_0008187) (Absence of secondary sex characteristics) and [HP:0010936](http://purl.obolibrary.org/obo/HP_0010936) (Abnormality of the lower urinary tract) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0003241](http://purl.obolibrary.org/obo/HP_0003241) (External genital hypoplasia) and [HP:0010936](http://purl.obolibrary.org/obo/HP_0010936) (Abnormality of the lower urinary tract) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0030349](http://purl.obolibrary.org/obo/HP_0030349) (Decreased circulating androgen level) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0030347](http://purl.obolibrary.org/obo/HP_0030347) (Abnormal circulating androgen level) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0010936](http://purl.obolibrary.org/obo/HP_0010936) (Abnormality of the lower urinary tract) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0010460](http://purl.obolibrary.org/obo/HP_0010460) (Abnormality of the female genitalia) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0008187](http://purl.obolibrary.org/obo/HP_0008187) (Absence of secondary sex characteristics) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0003241](http://purl.obolibrary.org/obo/HP_0003241) (External genital hypoplasia) 65.38%
- [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0000858](http://purl.obolibrary.org/obo/HP_0000858) (Menstrual irregularities) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) 65.38%


